Delivery Order SPE2DB24D8001-SPE2DB24FKYYF
Award Date
8/21/24
Potential Completion Date
8/22/24
Potential Value
$1.2K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. The $2,781.06 firm fixed-price delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) under the DLA Troop Support Medical's ECAT Generation V Program, which allows Dakota Drug, Inc. to provide a range of pharmaceutical and medical supplies to...
This federal contract award, SPE2DX15D8001|SPE2DX24FBQLK, was granted to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical division. The $1,343.17 firm fixed-price delivery order is for the supply of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product, with a completion date of February 16, 2024. Dakota Drug, Inc. is an established federal contractor, holding a $999,999,999.00 Indefinite Delivery Contract (IDC)...
This is a delivery order contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of BROVANA 15 MCG/2 ML SOLUTION UD 2ML, a prescription pharmaceutical product. The contract is a firm fixed price delivery order with a potential value of $3,230.03 and a completion date of January 10, 2024. There is no set-aside designation indicated for this award. As a prime contractor to DLA...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $3,539.65, is a firm fixed-price delivery order with no set-aside designation. The contract provides for the delivery of pharmaceutical products, including treatments for conditions such as diabetes, asthma, COPD, hypertension, and autoimmune disorders. Specific...
This federal contract award, identified as SPE2DX15D8003|SPE2DX24F7E0S, was issued by the Defense Logistics Agency (DLA) Troop Support Medical division to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,936.74 firm fixed-price delivery order is for the procurement of ANORO ELLIPTA 62.5-25 MCG INH 60S, a pharmaceutical product. The contract has an ultimate completion date of June 5, 2024 and was awarded on June 4, 2024. It is not set aside for any specific business...
This is a federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, by the Defense Logistics Agency (DLA). The $6,172.15 firm fixed-price delivery order contract is for the supply of Fluticasone-Salmeterol 230-21 12GM, a respiratory medication, to the DLA. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical's ECAT Generation V Program, which allows the company to provide a wide...
This federal contract award, valued at $1,371.74, was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract is for the delivery of AIRSUPRA 90-80 MCG INHALER 10.7GM, a pharmaceutical product, and has an ultimate completion date of December 31, 2024. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. government, particularly the Department of Defense. The...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $2,379.65 firm-fixed-price delivery order is for the provision of fluticasone propionate HFA 110 mcg 12 gm inhalers. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that allows Dakota Drug, Inc. to provide a comprehensive range of pharmaceutical...
This federal contract award, identified as SPE2DB24D8002 and SPE2DB25FJMMW, was made by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business operating as a for-profit subchapter S corporation. The $3,936.85 firm fixed-price delivery order is for the provision of fluticasone-salmeterol 230-21 12GM, a pharmaceutical product used to treat respiratory conditions such as asthma and COPD. Dakota Drug, Inc. has an existing Indefinite Delivery Contract...
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $3,628.80, is for the delivery of Trelegy Ellipta 200-62.5-25 60s inhalers. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2023. The award is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare...